Archives
-
Sodium Oxamate: LDH-A Workflow for TNBC
2026-09-11
Sodium Oxamate provides an aqueous, vehicle-controlled way to suppress LDH-A-linked lactate production and test metabolic dependencies in cancer cells. This workflow connects lactate measurements with apoptosis, histone lactylation, and SLFN5 assays, translating a TNBC study into practical experimental decisions.
-
Nebivolol: A Precision Tool for β1 Signaling
2026-09-11
Nebivolol hydrochloride is more than a selective β1 blocker: it is a strategic probe for separating receptor-driven cardiovascular phenotypes from broader pathway effects. This article connects β1-adrenoceptor pharmacology with drug-sensitized yeast evidence, practical assay design, translational positioning, and a disciplined interpretation of negative mTOR findings.
-
12-O-tetradecanoyl phorbol-13-acetate Workflows
2026-09-10
Build reproducible PKC and ERK/MAPK pathway activation assays with TPA, from rapid phospho-signaling measurements to skin cancer model design. The workflow also shows how to use TPA as a pathway-competence control when interpreting ICOS-driven T-cell experiments without confusing broad PKC activation with antigen-specific biology.
-
H-89 for PKA and cAMP Signaling Assays
2026-09-10
H-89 provides a rapid pharmacological route to test PKA involvement in cAMP signaling, Wnt-driven osteoblast metabolism, proliferation, and apoptosis assays. Its greatest value comes from pairing dose and timing matrices with orthogonal pathway controls rather than treating one inhibitor concentration as definitive proof of mechanism.
-
Stiripentol: LDH, Lactate, and Assay Design
2026-09-09
Stiripentol is a chemically distinct LDH inhibitor for studying lactate flux, neuronal excitability, and Dravet syndrome treatment research. This article connects astrocyte-neuron lactate shuttle modulation with histone lactylation findings and translates them into practical assay decisions.
-
Phenytoin for Dynamic Myelin Damage Assays
2026-09-09
Phenytoin provides a controllable sodium-channel activity perturbation for linking neuronal firing to early, potentially reversible myelin swelling. This workflow pairs concentration-controlled dosing with live imaging and electrophysiology rather than relying only on endpoint demyelination measurements.
-
Rottlerin: From PKCδ Mechanism to Translation
2026-09-08
Rottlerin is more than a PKC inhibitor for endpoint-driven assays: it can help translational researchers connect PKCδ signaling with proliferation, apoptosis, endothelial barrier biology, and host–pathogen entry. This thought-leadership perspective outlines how to use Rottlerin rigorously, interpret its selectivity, and extend findings across disease models without overstating preclinical evidence.
-
Vacuolin-1 Workflows for Lysosomal Exocytosis
2026-09-08
Vacuolin-1 provides a selective way to dissect Ca2+-dependent lysosomal exocytosis without broadly suppressing membrane trafficking. This guide connects practical cell-based assays with disease-model questions involving membrane repair, protease release, and growth factor signaling.
-
Fluorouracil: A Biomarker-Aware Research Guide
2026-09-07
Explore how Fluorouracil and 5-Fluorouracil connect thymidylate synthase inhibition with biomarker-aware cancer assays. This guide integrates product benchmarks with SMC2/SMC4 findings to improve experimental design across colon and breast cancer research.
-
Diminazene Aceturate: Mechanism and Research Use
2026-09-07
Diminazene Aceturate is a water- and DMSO-soluble diamidine used in trypanosome parasite research. A February 2024 mouse study used it as a pharmacological ACE2 activator and linked treatment to MasR–Sirt1-mediated mitochondrial biogenesis, but the result remains preclinical and does not establish a clinical indication.
-
Propidium Iodide: Assay Decisions Beyond Cell Death
2026-09-05
Propidium iodide is more than a red-fluorescent DNA intercalating dye: its signal must be matched to membrane status, DNA content, and sample handling. This guide connects rigorous PI assay design with lessons from rapid microwave processing of lactoferrin.
-
DPPH Radical: Mechanism and Antioxidant Screening
2026-09-04
DPPH (2,2-Diphenyl-1-Picrylhydrazyl) is a nitrogen-centered stable radical used for rapid, colorimetric in vitro antioxidant screening. Its violet-to-yellow reduction signal supports comparative radical-scavenging measurements, but results require matrix controls and orthogonal biochemical assays.
-
Mitoxantrone: Reading ABCG2 Resistance Correctly
2026-09-04
Mitoxantrone is more than a topoisomerase II inhibitor: its intracellular exposure can be reshaped by ABCG2-mediated efflux. This article presents a mechanistic framework for separating transporter effects from downstream drug resistance and designing more informative assays.
-
Thapsigargin for Calcium Signaling Workflows
2026-09-03
Thapsigargin provides a fast, tunable way to connect SERCA inhibition with cytosolic calcium elevation, ER stress, and programmed cell death. This workflow guide shows how to use it as a quantitative control in calcium signaling, apoptosis, viral necroptosis, and disease-model experiments while avoiding common interpretation errors.
-
0.4% Trypan Blue Solution: Practical Cell Viability Guide
2026-09-03
0.4% Trypan Blue Solution provides a membrane-exclusion method for cell viability measurement, cell counting, and rapid live/dead cell discrimination. It is intended for controlled biological research workflows, not for diagnostic, clinical, or medical use, and it should not be treated as a pathway-specific apoptosis assay.